Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real‐life Italian multicenter observational study of 250 patients
Gianluca Nazzaro(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Angelo Valerio Marzano(University of Milan), Giovanni Paolino(Vita-Salute San Raffaele University), Elisa Zavattaro(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Stefano Buffon(University of Milan), Emanuele Trovato(University of Siena), Chiara Astrua, Stefania Barruscotti(University of Pavia), Alice Verdelli(University of Florence), Santo Raffaele Mercuri(Vita-Salute San Raffaele University), Giulia Ciccarese(University of Foggia), Paolo Bortoluzzi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Mario Valenti(IRCCS Humanitas Research Hospital), Stefano Caccavale(University of Campania "Luigi Vanvitelli"), Rossella Lacava(Provincia Autonoma di Trento), Serena Giacalone(Ospedale Sant Antonio), Riccardo Balestri(Ospedale Santa Chiara), Vincenzo Pellegrino(University of Campania "Luigi Vanvitelli"), Laura Cristina Gironi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Andrea Carugno(University of Insubria), Paolo Sena(Ospedale Papa Giovanni XXIII), Elena Zappia(Magna Graecia University), Giulia Toni(University of Ferrara), Paolo Gisondi(University of Verona), Simone Ribero
Cited by 18
Related Papers
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332
Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives
|Dermatology|2020|292
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
|Journal of the European Academy of Dermatology and Venereology|2022|247
Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome
|Clinical & Experimental Immunology|2014|239
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study
|Journal of Allergy and Clinical Immunology|2020|160